Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200264384> ?p ?o ?g. }
- W4200264384 endingPage "e054222" @default.
- W4200264384 startingPage "e054222" @default.
- W4200264384 abstract "Patients undergoing surgery for severe aortic stenosis (SAS) can be treated with either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR). The choice of procedure depends on several factors, including the clinical judgement of the heart team and patient preferences, which are captured by actively informing and involving patients in a process of shared decision making (SDM). We synthesised the most up-to-date and accessible evidence on the benefits and risks that may be associated with TAVI versus SAVR to support SDM in this highly personalised decision-making process.Systematic review and meta-analysis.MEDLINE (Ovid), Embase (Ovid) and the Cochrane Central Register of Controlled Trials (CENTRAL; Wiley) were searched from January 2000 to August 2020 with no language restrictions. Reference lists of included studies were searched to identify additional studies.Randomised controlled trials (RCTs) that compared TAVI versus SAVR in patients with SAS and reported on all-cause or cardiovascular mortality, length of stay in intensive care unit or hospital, valve durability, rehospitalisation/reintervention, stroke (any stroke or major/disabling stroke), myocardial infarction, major vascular complications, major bleeding, permanent pacemaker (PPM) implantation, new-onset or worsening atrial fibrillation (NOW-AF), endocarditis, acute kidney injury (AKI), recovery time or pain were included.Two independent reviewers were involved in data extraction and risk of bias (ROB) assessment using the Cochrane tool (one reviewer extracted/assessed the data, and the second reviewer checked it). Dichotomous data were pooled using the Mantel-Haenszel method with random-effects to generate a risk ratio (RR) with 95% CI. Continuous data were pooled using the inverse-variance method with random-effects and expressed as a mean difference (MD) with 95% CI. Heterogeneity was assessed using the I2 statistic.8969 records were retrieved and nine RCTs (61 records) were ultimately included (n=8818 participants). Two RCTs recruited high-risk patients, two RCTs recruited intermediate-risk patients, two RCTs recruited low-risk patients, one RCT recruited high-risk (≥70 years) or any-risk (≥80 years) patients; and two RCTs recruited all-risk or 'operable' patients. While there was no overall change in the risk of dying from any cause (30 day: RR 0.89, 95% CI 0.65 to 1.22; ≤1 year: RR 0.90, 95% CI 0.79 to 1.03; 5 years: RR 1.09, 95% CI 0.98 to 1.22), cardiovascular mortality (30 day: RR 1.03, 95% CI 0.77 to 1.39; ≤1 year: RR 0.90, 95% CI 0.76 to 1.06; 2 years: RR 0.96, 95% CI 0.83 to 1.12), or any type of stroke (30 day: RR 0.83, 95% CI 0.61 to 1.14;≤1 year: RR 0.94, 95% CI 0.72 to 1.23; 5 years: RR 1.07, 95% CI 0.88 to 1.30), the risk of several clinical outcomes was significantly decreased (major bleeding, AKI, NOW-AF) or significantly increased (major vascular complications, PPM implantation) for TAVI vs SAVR. TAVI was associated with a significantly shorter hospital stay vs SAVR (MD -3.08 days, 95% CI -4.86 to -1.29; 4 RCTs, n=2758 participants). Subgroup analysis generally favoured TAVI patients receiving implantation via the transfemoral (TF) route (vs non-TF); receiving a balloon-expandable (vs self-expanding) valve; and those at low-intermediate risk (vs high risk). All RCTs were rated at high ROB, predominantly due to lack of blinding and selective reporting.No overall change in the risk of death from any cause or cardiovascular mortality was identified but 95% CIs were often wide, indicating uncertainty. TAVI may reduce the risk of certain side effects while SAVR may reduce the risk of others. Most long-term (5-year) results are limited to older patients at high surgical risk (ie, early trials), therefore more data are required for low risk populations. Ultimately, neither surgical technique was considered dominant, and these results suggest that every patient with SAS should be individually engaged in SDM to make evidence-based, personalised decisions around their care based on the various benefits and risks associated with each treatment.CRD42019138171." @default.
- W4200264384 created "2021-12-31" @default.
- W4200264384 creator A5001156294 @default.
- W4200264384 creator A5003560098 @default.
- W4200264384 creator A5004375284 @default.
- W4200264384 creator A5004915706 @default.
- W4200264384 creator A5005661019 @default.
- W4200264384 creator A5008704300 @default.
- W4200264384 creator A5019345660 @default.
- W4200264384 creator A5045436366 @default.
- W4200264384 creator A5051011711 @default.
- W4200264384 creator A5054807464 @default.
- W4200264384 creator A5066162295 @default.
- W4200264384 creator A5066388523 @default.
- W4200264384 creator A5067863584 @default.
- W4200264384 creator A5069841995 @default.
- W4200264384 creator A5075448540 @default.
- W4200264384 creator A5087489679 @default.
- W4200264384 creator A5089330773 @default.
- W4200264384 date "2021-12-01" @default.
- W4200264384 modified "2023-10-18" @default.
- W4200264384 title "Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis: a systematic review and meta-analysis" @default.
- W4200264384 cites W1158639029 @default.
- W4200264384 cites W154700364 @default.
- W4200264384 cites W1976605452 @default.
- W4200264384 cites W1999023967 @default.
- W4200264384 cites W1999811877 @default.
- W4200264384 cites W2067905792 @default.
- W4200264384 cites W2098923148 @default.
- W4200264384 cites W2119605658 @default.
- W4200264384 cites W2131958422 @default.
- W4200264384 cites W2132585880 @default.
- W4200264384 cites W2146716477 @default.
- W4200264384 cites W2158796716 @default.
- W4200264384 cites W2165258820 @default.
- W4200264384 cites W2166973706 @default.
- W4200264384 cites W2299856223 @default.
- W4200264384 cites W2319303506 @default.
- W4200264384 cites W2324073140 @default.
- W4200264384 cites W2333499599 @default.
- W4200264384 cites W2412194788 @default.
- W4200264384 cites W2510087449 @default.
- W4200264384 cites W2510609796 @default.
- W4200264384 cites W2520498212 @default.
- W4200264384 cites W2526461845 @default.
- W4200264384 cites W2530256705 @default.
- W4200264384 cites W2546501932 @default.
- W4200264384 cites W2547280979 @default.
- W4200264384 cites W2547963952 @default.
- W4200264384 cites W2561598874 @default.
- W4200264384 cites W2583534582 @default.
- W4200264384 cites W2583898687 @default.
- W4200264384 cites W2588681363 @default.
- W4200264384 cites W2589284515 @default.
- W4200264384 cites W2596188051 @default.
- W4200264384 cites W2605849388 @default.
- W4200264384 cites W2631733658 @default.
- W4200264384 cites W2732888504 @default.
- W4200264384 cites W2751630023 @default.
- W4200264384 cites W2755651977 @default.
- W4200264384 cites W2766555186 @default.
- W4200264384 cites W2766728383 @default.
- W4200264384 cites W2766791324 @default.
- W4200264384 cites W2775394904 @default.
- W4200264384 cites W2793059091 @default.
- W4200264384 cites W2795732318 @default.
- W4200264384 cites W2801749827 @default.
- W4200264384 cites W2890002418 @default.
- W4200264384 cites W2896197760 @default.
- W4200264384 cites W2897839923 @default.
- W4200264384 cites W2904071240 @default.
- W4200264384 cites W2911992158 @default.
- W4200264384 cites W2913306454 @default.
- W4200264384 cites W2921388585 @default.
- W4200264384 cites W2922215374 @default.
- W4200264384 cites W2941677670 @default.
- W4200264384 cites W2942749929 @default.
- W4200264384 cites W2944962144 @default.
- W4200264384 cites W2958567821 @default.
- W4200264384 cites W2958719459 @default.
- W4200264384 cites W2967552381 @default.
- W4200264384 cites W2976189003 @default.
- W4200264384 cites W2977618624 @default.
- W4200264384 cites W2981517894 @default.
- W4200264384 cites W2983323654 @default.
- W4200264384 cites W2983368451 @default.
- W4200264384 cites W2984243438 @default.
- W4200264384 cites W2996258364 @default.
- W4200264384 cites W2996584337 @default.
- W4200264384 cites W3003306195 @default.
- W4200264384 cites W3003357546 @default.
- W4200264384 cites W3003587193 @default.
- W4200264384 cites W3003600663 @default.
- W4200264384 cites W3003964842 @default.
- W4200264384 cites W3005455248 @default.
- W4200264384 cites W3006725003 @default.
- W4200264384 cites W3011654546 @default.
- W4200264384 cites W3012046945 @default.